Related references
Note: Only part of the references are listed.Effect of Technosphere Inhaled Insulin on Quality of Life and Treatment Satisfaction
Mark Peyrot et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2010)
Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
Julio Rosenstock et al.
LANCET (2010)
How Does Treatment Satisfaction Work? Modeling determinants of treatment satisfaction and preference
Mark Peyrot et al.
DIABETES CARE (2009)
Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus
Mark Peyrot et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
Julio Rosenstock et al.
DIABETES CARE (2008)
The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy:: the evaluation of Exubera® as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial
S. Del Prato et al.
DIABETIC MEDICINE (2008)
Factors affecting use of insulin pens by patients with type 2 diabetes
Richard R. Rubin et al.
DIABETES CARE (2008)
How doctors choose medications to treat type 2 diabetes - A national survey of specialists and academic generalists
Richard W. Grant et al.
DIABETES CARE (2007)
Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes
Jay S. Skyler et al.
DIABETES CARE (2007)
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea
AH Barnett et al.
DIABETES CARE (2006)
Resistance to insulin therapy among patients and providers - Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
M Peyrot et al.
DIABETES CARE (2005)
Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes - A randomized, controlled trial
J Rosenstock et al.
ANNALS OF INTERNAL MEDICINE (2005)
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects - A 16-month, randomized, comparative trial
JS Skyler et al.
DIABETES CARE (2005)
Factors that influence prescribing decisions
GT Schumock et al.
ANNALS OF PHARMACOTHERAPY (2004)
Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes - Results of a 6-month, randomized, comparative trial
PA Hollander et al.
DIABETES CARE (2004)
Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes -: Results of a 6-month, randomized, comparative trial
T Quattrin et al.
DIABETES CARE (2004)
Patient satisfaction and glycemic control after 1 year with inhaled insulin (exubera) patients with type 1 or type 2 diabetes
J Rosenstock et al.
DIABETES CARE (2004)
Share Paper
